Title |
Management of sexual dysfunction due to antipsychotic drug therapy
|
---|---|
Published in |
Cochrane database of systematic reviews, November 2012
|
DOI | 10.1002/14651858.cd003546.pub3 |
Pubmed ID | |
Authors |
Hannah M Schmidt, Mathias Hagen, Levente Kriston, Karla Soares‐Weiser, Nicola Maayan, Michael M Berner |
Abstract |
Psychotropic drugs are associated with sexual dysfunction. Symptoms may concern penile erection, lubrication, orgasm, libido, retrograde ejaculation, sexual arousal, or overall sexual satisfaction. These are major aspects of tolerability and can highly affect patients' compliance. |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 20% |
United Kingdom | 4 | 20% |
India | 2 | 10% |
Unknown | 10 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 13 | 65% |
Practitioners (doctors, other healthcare professionals) | 6 | 30% |
Scientists | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 151 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | 1% |
Poland | 1 | <1% |
India | 1 | <1% |
Unknown | 147 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 24 | 16% |
Student > Bachelor | 17 | 11% |
Researcher | 16 | 11% |
Student > Postgraduate | 12 | 8% |
Student > Doctoral Student | 12 | 8% |
Other | 28 | 19% |
Unknown | 42 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 52 | 34% |
Psychology | 21 | 14% |
Nursing and Health Professions | 11 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
Agricultural and Biological Sciences | 5 | 3% |
Other | 11 | 7% |
Unknown | 46 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2022.
All research outputs
#2,237,977
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#4,617
of 11,499 outputs
Outputs of similar age
#15,011
of 192,725 outputs
Outputs of similar age from Cochrane database of systematic reviews
#90
of 239 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,725 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 239 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.